PENNINGTON BIOMEDICAL RESEARCH FOUNDATION (EIN 581767810) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1988

Legal Domicile

Principal Officer

JANET OLSON

Phone

2257632500

Tax Period

2024-07-01 to 2025-06-30

PENNINGTON BIOMEDICAL RESEARCH FOUNDATION, founded in 1988, is a community nonprofit in the Medical Research sector that reported $4.5M in total revenue in fiscal year 2024. Revenue fell 23% from the prior year — a significant decline worth monitoring. Expenses of $4.2M left a modest 7% surplus.

Mission

THE MISSION OF THE PENNINGTON BIOMEDICAL RESEARCH FOUNDATION IS TO SUPPORT THE WORK OF LSU'S PENNINGTON BIOMEDICAL RESEARCH CENTER, WHICH AIMS TO DISCOVER THE TRIGGERS OF CHRONIC DISEASES THROUGH INNOVATIVE REASEARCH THAT IMPROVES HUMAN HEALTH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,558,960

Program Service Revenue $963,005

Investment Income $1,792,035

Other Revenue $169,977

TOTAL REVENUE $4,483,977

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,717,545

Fundraising Expenses $1,015,771

Program Expenses $2,627,598

Other Expenses $2,446,204

TOTAL EXPENSES $4,163,749

Year-over-Year Comparison

	2024	2023	Change
Revenue	$4,483,977	$5,834,269	-0.2%
Expenses	$4,163,749	$3,927,570	+0.1%
Net Income	$320,228	$1,906,699	-0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$516,088

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ANN WILKINSON	BOARD MEMBER	1.00	Director	$0	$0	$0
ANNETTE D BARTON	SECRETARY	1.00	Officer Director	$0	$0	$0
ARTHUR E FAVRE	BOARD MEMBER	1.00	Director	$0	$0	$0
C KRIS KIRKPATRICK	BOARD MEMBER	1.00	Director	$0	$0	$0
CHARLES LAMAR	VICE CHAIR	1.00	Officer Director	$0	$0	$0
CHRISTEL C SLAUGHTER PHD	BOARD MEMBER (THRU 12/24)	1.00	Director	$0	$0	$0
CLAUDE B PENNINGTON III	BOARD MEMBER	1.00	Director	$0	$0	$0
DR JOHN KIRWAN PHD	EX-OFFICIO	1.00	Director	$0	$0	$0
FRAN HARVEY	BOARD MEMBER	1.00	Director	$0	$0	$0
GEORGE D NELSON JR	CHAIRPERSON	1.00	Officer Director	$0	$0	$0
JOHN SPAIN	BOARD MEMBER (THRU 4/25)	1.00	Director	$0	$0	$0
LORI MELANCON	EX-OFFICIO	1.00	Director	$0	$0	$0
MARVIN BORGMEYER	BOARD MEMBER	1.00	Director	$0	$0	$0
MONICA ZUMO	TREASURER	1.00	Officer Director	$0	$0	$0
PAULA P DE LA BRETONNE	BOARD MEMBER	1.00	Director	$0	$0	$0
REBECCA BONIOL	EX-OFFICIO	1.00	Director	$0	$0	$0
SHARON WESTON BROOME	EX-OFFICIO	1.00	Director	$0	$0	$0
SID EDWARDS	EX-OFFICIO	1.00	Director	$0	$0	$0
TOM EASTERLY	BOARD MEMBER	1.00	Director	$0	$0	$0
VENEETH IYENGAR	BOARD MEMBER	1.00	Director	$0	$0	$0
WILLIAM TATE IV	EX-OFFICIO	1.00	Director	$0	$0	$0
ANDRE GREENE	CHIEF FINANCIAL OFFICER (THRU 11/24)	40.00	Officer	$158,523	$6,579	$165,102
BRIANNA BARRETT	CHIEF DEVELOPMENT OFFICER	40.00	Officer	$244,430	$12,348	$256,778
JANET L OLSON	PRESIDENT/CEO	40.00	Officer	$94,208	$0	$94,208

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$4,483,977	$4,163,749	$29,642,935	$320,228
2024	$5,834,269	$3,927,570	$29,530,991	$1,906,699
2023	$4,845,894	$4,067,974	$26,184,075	$777,920
2022	$5,462,788	$6,271,883	$29,937,917	$-809,095
2021	$5,388,620	$4,492,722	$26,941,603	$895,898
2020	$4,040,552	$4,358,502	$25,592,081	$-317,950
2019	$4,745,072	$3,222,592	$27,254,274	$1,522,480
2018	$4,090,823	$3,732,738	$26,146,539	$358,085

PENNINGTON BIOMEDICAL RESEARCH FOUNDATION